Literature DB >> 20709559

Facile synthesis of octahydrobenzo[h]isoquinolines: novel and highly potent D1 dopamine agonists.

Lisa A Bonner1, Benjamin R Chemel, Val J Watts, David E Nichols.   

Abstract

The octahydrobenzo[h]isoquinoline scaffold is of interest as a conformationally-restricted phenethylamine that may be useful for constructing biologically active products. Surprisingly, however, no tractable synthesis of this ring system has been reported. We now describe a facile method for obtaining this framework, and illustrate that our approach is easily amenable to substitutions at the 5-position. Importantly, we demonstrate that the 7,8-dihydroxy-5-phenyl-substituted ligand is an extremely potent, high-affinity, full D1 dopamine receptor-selective agonist. Copyright (c) 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20709559      PMCID: PMC2941879          DOI: 10.1016/j.bmc.2010.07.052

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  35 in total

1.  Dihydrexidine, a full dopamine D1 agonist, reduces MPTP-induced parkinsonism in monkeys.

Authors:  J R Taylor; M S Lawrence; D E Redmond; J D Elsworth; R H Roth; D E Nichols; R B Mailman
Journal:  Eur J Pharmacol       Date:  1991-07-09       Impact factor: 4.432

2.  Short- and long-term heterologous sensitization of adenylate cyclase by D4 dopamine receptors.

Authors:  V J Watts; M N Vu; B L Wiens; V Jovanovic; H H Van Tol; K A Neve
Journal:  Psychopharmacology (Berl)       Date:  1999-01       Impact factor: 4.530

3.  Congeners of the alpha conformer of dopamine derived from octahydrobenz[h]isoquinoline.

Authors:  J G Cannon; T Lee; F L Hsu; J P Long; J R Flynn
Journal:  J Med Chem       Date:  1980-05       Impact factor: 7.446

4.  Dihydrexidine, a novel full efficacy D1 dopamine receptor agonist.

Authors:  D M Mottola; W K Brewster; L L Cook; D E Nichols; R B Mailman
Journal:  J Pharmacol Exp Ther       Date:  1992-07       Impact factor: 4.030

5.  Inhibition of the sympathetic nervous system by a series of heterocyclic congeners of dopamine.

Authors:  F M Sharabi; J P Long; J G Cannon; G J Hatheway
Journal:  J Pharmacol Exp Ther       Date:  1976-12       Impact factor: 4.030

6.  9-Dihydroxy-2,3,7,11b-tetrahydro-1H-naph[1,2,3-de]isoquinoline: a potent full dopamine D1 agonist containing a rigid-beta-phenyldopamine pharmacophore.

Authors:  D Ghosh; S E Snyder; V J Watts; R B Mailman; D E Nichols
Journal:  J Med Chem       Date:  1996-01-19       Impact factor: 7.446

7.  Centrally acting emetics. 10. Rigid dopamine congeners derived from octahydrobenzo[f]quinoline.

Authors:  J G Cannon; G J Hatheway
Journal:  J Med Chem       Date:  1976-08       Impact factor: 7.446

8.  Conformational analysis of D1 dopamine receptor agonists: pharmacophore assessment and receptor mapping.

Authors:  D M Mottola; S Laiter; V J Watts; A Tropsha; S D Wyrick; D E Nichols; R B Mailman
Journal:  J Med Chem       Date:  1996-01-05       Impact factor: 7.446

9.  Congeners of the beta conformer of dopamine derived from cis- and trans-octahydrobenzo[f]quinoline and trans-octahydrobenzo[g]quinoline.

Authors:  J G Cannon; T Lee; H D Goldman; J P Long; J R Flynn; T Verimer; B Costall; R J Naylor
Journal:  J Med Chem       Date:  1980-01       Impact factor: 7.446

10.  Dopamine D1 receptors: efficacy of full (dihydrexidine) vs. partial (SKF38393) agonists in primates vs. rodents.

Authors:  V J Watts; C P Lawler; J H Gilmore; S B Southerland; D E Nichols; R B Mailman
Journal:  Eur J Pharmacol       Date:  1993-09-28       Impact factor: 4.432

View more
  3 in total

1.  Identification of a 2-phenyl-substituted octahydrobenzo[f]quinoline as a dopamine D₃ receptor-selective full agonist ligand.

Authors:  Alia H Clark; John D McCorvy; Jason M Conley; Whitney K Williams; Markondaiah Bekkam; Val J Watts; David E Nichols
Journal:  Bioorg Med Chem       Date:  2012-09-08       Impact factor: 3.641

2.  Mapping the catechol binding site in dopamine D₁ receptors: synthesis and evaluation of two parallel series of bicyclic dopamine analogues.

Authors:  Lisa A Bonner; Uros Laban; Benjamin R Chemel; Jose I Juncosa; Markus A Lill; Val J Watts; David E Nichols
Journal:  ChemMedChem       Date:  2011-04-28       Impact factor: 3.466

3.  Investigation of D₁ receptor-agonist interactions and D₁/D₂ agonist selectivity using a combination of pharmacophore and receptor homology modeling.

Authors:  Marcus Malo; Lars Brive; Kristina Luthman; Peder Svensson
Journal:  ChemMedChem       Date:  2012-02-07       Impact factor: 3.466

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.